• Search
      • Search Interactions Search Categories
    • Browse
      • Browse Categories Browse Sources
    • Information
      • About Publications Interaction Types & Directionalities Interaction Score & Query Score API Documentation FAQ Known Data Clients News Contact
    • Downloads
      • Data Source Code

TRAMADOL Drug Record

  • Summary
  • Interactions
  • Claims
  • TRAMADOL chembl:CHEMBL1237044 Approved

    Alternate Names:

    TRAMADOL
    ETS6103
    ETS-6103
    ULTRAM
    ULTRACET
    TILODOL®
    TRAMACET®
    (1RS,2RS)-2-[(DIMETHYLAMINO)METHYL]-1-(3-METHOXYPHENYL)-CYCLO-HEXANOL
    MAXITRAM®
    chemidplus:2914-77-4
    pubchem.compound:5523
    chembl:CHEMBL1237044

    Drug Info:

    Drug Class analgesics, opioid
    Year of Approval 1995
    FDA Approval approved
    Drug Class Small Molecule
    Drug Indications analgesic
    (3 More Sources)

    Publications:

    Sagata et al., 2002, Tramadol inhibits norepinephrine transporter function at desipramine-binding sites in cultured bovine adrenal medullary cells., Anesth. Analg.
    Frink et al., 1996, Influence of tramadol on neurotransmitter systems of the rat brain., Arzneimittelforschung
    Berrocoso et al., 2009, Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression., Int. J. Neuropsychopharmacol.
    Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
    Barakat A, 2019, Revisiting Tramadol: A Multi-Modal Agent for Pain Management., CNS Drugs
    Muriel J et al., 2019, Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients., Basic Clin Pharmacol Toxicol
    Liu YC et al., 2012, Human mu-opioid receptor gene A118G polymorphism predicts the efficacy of tramadol/acetaminophen combination tablets (ultracet) in oxaliplatin-induced painful neuropathy., Cancer
    Potschka et al., 2000, Anticonvulsant and proconvulsant effects of tramadol, its enantiomers and its M1 metabolite in the rat kindling model of epilepsy., Br. J. Pharmacol.
    Grond et al., 2004, Clinical pharmacology of tramadol., Clin Pharmacokinet
    Raffa et al., 1992, Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic., J. Pharmacol. Exp. Ther.
    Minami et al., 2007, Pharmacological aspects of the effects of tramadol on G-protein coupled receptors., J. Pharmacol. Sci.
    Gillen et al., 2000, Affinity, potency and efficacy of tramadol and its metabolites at the cloned human mu-opioid receptor., Naunyn Schmiedebergs Arch. Pharmacol.
    Ide et al., 2006, Mu opioid receptor-dependent and independent components in effects of tramadol., Neuropharmacology
    Zanger UM et al., 2008, Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation., Anal Bioanal Chem
    Barann et al., 2006, Effects of tramadol and O-demethyl-tramadol on human 5-HT reuptake carriers and human 5-HT3A receptors: a possible mechanism for tramadol-induced early emesis., Eur. J. Pharmacol.
    Driessen et al., 1992, Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro., Br. J. Pharmacol.
    Sun et al., 2003, Tramadol reduces the 5-HTP-induced head-twitch response in mice via the activation of mu and kappa opioid receptors., Life Sci.
    Wendt FR et al., 2020, A genome-wide association study of tramadol metabolism from post-mortem samples., Pharmacogenomics J
    Horishita et al., 2006, The tramadol metabolite, O-desmethyl tramadol, inhibits 5-hydroxytryptamine type 2C receptors expressed in Xenopus Oocytes., Pharmacology
    Ogata et al., 2004, The inhibitory effects of tramadol on 5-hydroxytryptamine type 2C receptors expressed in Xenopus oocytes., Anesth. Analg.
    Gong L et al., 2014, PharmGKB summary: tramadol pathway., Pharmacogenet Genomics
    Faron-Górecka et al., 2004, Long-term exposure of rats to tramadol alters brain dopamine and alpha 1-adrenoceptor function that may be related to antidepressant potency., Eur. J. Pharmacol.
    Tzvetkov MV et al., 2011, Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol., Clin Pharmacol Ther
    Wentland et al., 2009, Syntheses and opioid receptor binding properties of carboxamido-substituted opioids., Bioorg. Med. Chem. Lett.
  • TRAMADOL   RGL4

    Interaction Score: 6.87

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    30971809


    Sources:
    PharmGKB

  • TRAMADOL   ICA1

    Interaction Score: 6.87

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    30971809


    Sources:
    PharmGKB

  • TRAMADOL   RFPL4B

    Interaction Score: 6.87

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    30971809


    Sources:
    PharmGKB

  • TRAMADOL   HCN1

    Interaction Score: 6.87

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    30971809


    Sources:
    PharmGKB

  • TRAMADOL   ARRB2

    Interaction Score: 1.72

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    30549211


    Sources:
    PharmGKB

  • TRAMADOL   SULT1A3

    Interaction Score: 1.14

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    PharmGKB

  • TRAMADOL   SLC6A2

    Interaction Score: 0.62

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Trial Name PTI-601
    Novel drug target Established target
    Trial Name tramadol extended-release,Raliva ER

    PMIDs:
    11916794 8955860 19341511 11752352 31004280


    Sources:
    TdgClinicalTrial TEND

  • TRAMADOL   SLC22A1

    Interaction Score: 0.49

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    21562485


    Sources:
    PharmGKB

  • TRAMADOL   OPRM1

    Interaction Score: 0.46

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name tramadol,Tridural, Ryzolt
    Trial Name tramadol hydrochloride,Ultram
    Trial Name tramadol extended-release,Raliva ER

    PMIDs:
    30549211 21837673 10991912 8955860 15509185 1309873 11752352 17380034 10961373 16793069 31004280


    Sources:
    TdgClinicalTrial TEND PharmGKB

  • TRAMADOL   SLC6A4

    Interaction Score: 0.4

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Trial Name PTI-601
    Novel drug target Established target
    Trial Name tramadol extended-release,Raliva ER

    PMIDs:
    8955860 16427041 1596676 31004280


    Sources:
    TdgClinicalTrial TEND

  • TRAMADOL   HTR2C

    Interaction Score: 0.34

    Interaction Types & Directionality:
    antagonist (inhibitory)

    Interaction Info:
    Trial Name tramadol,Tridural, Ryzolt
    Trial Name tramadol hydrochloride,Ultram
    Trial Name tramadol extended-release,Raliva ER

    PMIDs:
    16679816 15105221


    Sources:
    TdgClinicalTrial TEND TTD

  • TRAMADOL   OPRD1

    Interaction Score: 0.34

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:

    PMIDs:
    19027293 30549211 31004280


    Sources:
    PharmGKB

  • TRAMADOL   OPRK1

    Interaction Score: 0.2

    Interaction Types & Directionality:
    agonist (activating)

    Interaction Info:
    Trial Name PTI-601
    Novel drug target Established target
    Trial Name tramadol extended-release,Raliva ER

    PMIDs:
    12570923 31004280


    Sources:
    TdgClinicalTrial TEND

  • TRAMADOL   CYP2B6

    Interaction Score: 0.14

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    24849324


    Sources:
    PharmGKB

  • TRAMADOL   BDNF

    Interaction Score: 0.11

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    15464068


    Sources:
    NCI

  • TRAMADOL   CYP3A5

    Interaction Score: 0.07

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    18695978


    Sources:
    PharmGKB

  • TRAMADOL   CYP3A4

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    24849324


    Sources:
    PharmGKB

  • TRAMADOL   CYP2D6

    Interaction Score: 0.01

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    FDA

  • TEND: TRAMADOL

    • Version: 01-August-2011

    Alternate Names:

    Drug Info:
    Year of Approval 1995
    Drug Class analgesics, opioid

    Publications:

  • TdgClinicalTrial: TRAMADOL

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications analgesic
    Drug Class Small Molecule
    FDA Approval approved

    Publications:

  • NCI: TRAMADOL

    • Version: 14-September-2017

    Alternate Names:
    C29507 NCI drug code

    Drug Info:

    Publications:
    Faron-Górecka et al., 2004, Long-term exposure of rats to tramadol alters brain dopamine and alpha 1-adrenoceptor function that may be related to antidepressant potency., Eur. J. Pharmacol.

  • PharmGKB: tramadol

    • Version: 18-August-2020

    Alternate Names:

    Drug Info:

    Publications:
    Muriel J et al., 2019, Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients., Basic Clin Pharmacol Toxicol
    Wendt FR et al., 2020, A genome-wide association study of tramadol metabolism from post-mortem samples., Pharmacogenomics J
    Tzvetkov MV et al., 2011, Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol., Clin Pharmacol Ther

  • TTD: Tramadol

    • Version: 2020.06.01

    Alternate Names:
    D05GKD TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL1237044

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • FDA: Tramadol

    • Version: 04-September-2020

    Alternate Names:

    Drug Info:

    Publications:

Disclaimer: This resource is intended for purely research purposes. It should not be used for emergencies or medical or professional advice.

A finding of a drug-gene interaction or potentially druggable category does not necessarily indicate effectiveness (or lack thereof) of any drug or treatment regimen. A finding of no interaction or no potentially druggable category does not necessarily indicate lack of effectiveness of any drug or treatment regimen. Drug-gene interactions or potentially druggable categories are not presented in ranked order of potential or predicted efficacy.

The dgidb.org website does not provide any medical or healthcare products, services or advice, and is not for medical emergencies or urgent situations. IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY, CALL YOUR DOCTOR OR 911 IMMEDIATELY. Information contained on this website is not a substitute for a doctor's medical judgment or advice. We recommend that you discuss your specific, individual health concerns with your doctor or health care professional.

DGIdb (v4.2.0 - sha1 afd9f30b) • Last updated 2020-10-21